Cargando…

Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells

Ischemic stroke is a debilitating disease for which there are currently no effective treatments besides the clot-buster, tissue plasminogen activator (t-PA), which is administered to less than 10% of patients due to a limited (4.5 h) time window of efficacy. Thus, there is an urgent need for novel t...

Descripción completa

Detalles Bibliográficos
Autores principales: Broughton, Brad R. S., Lim, Rebecca, Arumugam, Thiruma V., Drummond, Grant R., Wallace, Euan M., Sobey, Christopher G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547279/
https://www.ncbi.nlm.nih.gov/pubmed/23335880
http://dx.doi.org/10.3389/fncel.2012.00066

Ejemplares similares